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As one who has worked on the identification and
quantification of apoptotic events in tissue sections (most
notably of the intestine) since about 1974, I had become
accustomed to a marked reluctance, in some cases overt
hostility, to accepting the concept of apoptotic death. I am
therefore extremely gratified to observe that the idea of
apoptotis occurring in normal, tumour and cytotoxically
exposed tissue is not only widely accepted but has burgeoned
into a rapidly expanding field of study.
I have listened to many scientific presentations and read a
large number of poster presentations and papers, all ofwhich
present measurements of apoptotic yield in a variety of
experimental circumstances, usually using sections of tissue,
cell suspensions from tissues or cells in culture, and
presenting the data in the form of an apoptotic index (AI)
(i.e. a measure of the number of apoptotic events or cell
deaths expressed as a ratio or percentage of all cells present
or all cells counted). I feel that several words of caution are
perhaps appropriate at this time.
Those individuals who count apoptotic events and wish to
express relative changes in the numbers of these events by
way of an apoptotic index are in danger offinding themselves
in a similar situation to that which cell kineticists went
through in the 1950s and 1960s when presenting labelling
indices that were a measure of a proportion of S-phase cells
in tissue sections or cell suspensions. The problems faced
were as follows:
1. The labelling index (LI) is directly dependent on the
number of S-phase cells and the duration of S-phase. The
latter was either largely unknown or assumed to be
identical in all situations studied. In retrospect, S-phase
durations did not vary enormously in the majority of
cases. Little is known about the duration of apoptosis in
most situations (see below).
2. The LI in many normal tissues also exhibits daily
fluctuations (circadian rhythms), which make isolated
single measurements difficult to assess. The AI shows
similar rhythms at least in one tissue, the intestine
(Potten, 1977; Potten et al., 1976).
3. The denominator in the labelling index calculation was,
and largely still is, a major problem in that it contains
not only cells in other phases of the cell cycle (which is
what is assumed by most people) but also non-cycling
cells (Go or quiescent populations), cell types unrelated to
the tissue of interest (connective tissue, infiltrating
lymphocytes, etc), differentiated non-cycling cells (the
functional cells of the tissues of interest) and any dead or
dying cells that were not clearly recognisable as dead.
Very similar problems associated with the denominator
can be expected for Al measurement.
4. These early cell kinetics studies rarely took into account
the fact that most renewing tissues, and probably most
tumours, have a hierarchical organisation with the
predominant dividing transit cells possibly having
different cell cycle characteristics from the important
and relevant stem or clonogenic compartments. In my
view, mainly for this reason, the great expectation in cell
kinetics of understanding tumour and normal cell
biology so as to facilitate therapy was never fully
realised. It is, however, true that most workers in the
field of proliferation analyses now have a reasonable
appreciation of these problems and limitations. Little is
known about the hierarchical dependence of apoptosis
except in the gastrointestinal tract.
The points outlined above apply equally well to the
determination of an apoptotic index, and, in addition, there
may be other considerations that can influence this
parameter.
What I would like to attempt here is to consider these
problems and others in relation to apoptotic index
measurements. Rather than attempt to cover all tissues and
cell culture systems I should like to considerjust one case, the
small intestine, which has been fairly extensively studied over
the years. For extensive reviews of the cellular and kinetic
organisation see Wright and Alison (1984) and Potten (1995).
This could be used as a model for other situations.
Inevitably, therefore, I will draw heavily on our own
experiences in studying this tissue. I do not wish to create a
negative atmosphere concerning apoptotic index but merely
to draw attention to potential problems and pitfalls.
Duration of apoptosis and detection efficiency of small
fragments
The duration of the apoptotic process is largely unknown.
The microscopically visible part of the process will depend
upon the characteristics of the tissue or cell system being
studied, the degree of fragmentation that occurs during the
apoptotic process, the mechanisms of removal of the
apoptotic fragments and the sensitivity of the detection
procedures. Some of these aspects have been studied in the
gastrointestinal tract, where we have demonstrated that
irradiation-induced apoptosis results in the production of,
on average, three apoptotic fragments; but there is a wide
range of values (Figure 1). These fragments are removed in
the intestinal epithelium by phagocytic digestion within
healthy neighbouring epithelial cells that are themselves
migrating from the crypt to the villus in the small intestine.
In other situations the removal is achieved by macrophages.
In either case the fragments become smaller with the passage
of time and in the intestine also move, or are displaced, along
the crypt-villus axis (Ijiri and Potten, 1983, 1987a, b; Li et
al., 1992). However, some fragments may be incorporated
into the cytoplasm of stem cells or Paneth cells at the base of
the crypt, which either do not move or have a very slow
turnover. A few fragments may also be extruded directly into
the lumen of the crypt. Hence, the loss or removal process is
complex. There are even suggestions from our own
unpublished data that the number of fragments generated
may vary with the severity or nature of cytotoxic exposure.
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Figure 1 The number of apoptotic fragments associated with
apoptotic events in crypt whole-mount preparations for
spontaneous apoptosis (a) and 3 h after 1 Gy of y-rays (b).
The determination of the half-life of these fragments
depends on the efficiency with which small fragments can be
detected. Some such fragments may not in fact contain
condensed chromatin, being merely cytoplasmic remnants of
the dying cell, and are very difficult to detect. Studies
involving the temporal events leading to the production and
removal of apoptosis following various cytotoxic agents
suggest that the half-life may even vary depending on the
cytotoxic agent being considered (Potten, 1977; Potten et al.,
1977; Ijiri and Potten, 1983, 1987a). Following an S-phase-
specific agent such as hydroxyurea the half-life appears to be
about 3.5 h, while removal of apoptosis generated by
radiation, which is less cell cycle specific, would appear to
be about 12 h (Figure 2) (see also Merritt et al., 1990). These
must be regarded as very crude estimates of the half-life of
apoptotic bodies and probably represent upper limits as the
yields observed at these later times will be influenced by cells
entering apoptosis at the same times. Studies in the
developing kidney of the rat in which the fall in apoptosis
was measured, following injection of epidermal growth factor
(which was assumed to block developmental apoptosis in this
system) suggested that the clearance time was very short at
1-2 h (Coles et al., 1993). However, it is possible that during
development many cellular processes proceed at a faster rate
than in adults.
Although these half-lives differ by a factor of more than 2,
they are of the same order ofmagnitude as the duration of S-
phase. Hence, the apoptotic index may loosely be compared
with proliferative parameters such as the labelling index and
c
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Figure 2 The rate of removal of apoptotic fragments in sections
of crypts after various treatments. The half-life can be estimated
from such decay curves. Many unpublished data have been
pooled. Each point is the mean of four mice (50 crypts per
mouse). No obvious differences could be detected when the data
for different doses were analysed separately. This is also indicated
by the amount of scatter of the individual datum points. (a)
Radiation, 0.05-12Gy (eight experiments). (b) Hydroxyurea, 1-
10mg per mouse (three experiments).
may under some circumstances be used like a labelling index.
In fact, there may be value in considering the ratio of LI to
Al, which effectively removes the uncertainties relating to the
denominator (Allan et al., 1992). However, it should be
realised that a factor of 2 difference in the duration of
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apoptosis in two samples would result in a two-fold difference
in apoptotic index, although the number of cells dying would
be the same.
Fragments versus dying cells
Clearly, the identification of an apoptotic fragment indicates
that a cell has died nearby, but, because a dying cell breaks
up into several fragments, a fragment score does not equal a
cell death score. Several authors attempt to overcome this by
scoring a cluster of fragments as one cell death event (see, for
example, Coles et al., 1993; Hall et al., 1994), but this tends
to be somewhat subjective. Ideally, the fragment distribution
should be determined (as above) using thick sections or,
better still, whole mounts of pieces of tissue under
circumstances in which the cell deaths are more discrete,
separated entities and, hence, clustered fragments can be
more reliably assessed (Potten, 1977; Ijiri and Potten, 1983,
1987a). Another potential problem here is the fact that in
different tissues and under different conditions the levels of
fragmentation may vary and, in some cases, fragmentation
itselt may be absent, as in some in vitro models.
Geometric considerations
There are also geometric considerations that will influence
the apoptotic index seen in sections. If fragments are scored
and expressed as an index relative to normal healthy cells
(usually identified by their nuclei), the index will tend to
underestimate the true incidence because fragments are
smaller than healthy nuclei and are therefore less likely to
be 'caught' in a given section. Conversely, if clusteres are
scored, the incidence may be overestimated as the area of a
cluster may be larger than that of a healthy nucleus.
However, the situation may be more complex in this case as
single fragments would probably also be counted as an
apoptotic event, and these are smaller than a healthy
nucleus. These considerations are similar to those described
by Tannock (1976) and Potten et al. (1988) for correcting
mitotic counts.
We have addressed these geometric questions in sections
of the small intestine by comparing counts made from
sections with counts in whole mounts of crypts in which all
the nuclei and all the apoptotic events with their fragments
are present (Potten et al., 1988; Merritt et al., 1996). In the
crypt, the situation is further complicated in sections
because apoptotic fragments tend to be centripetally
displaced and because counting must be performed on
longitudinal sections that pass through the central axis of
the crypt. These facts increase the chances of detecting
fragments. Using whole mounts and sections prepared from
the same intestine of irradiated animals, we have shown that
sections detect about 20-30% of all apoptotic events and
50% of all fragments that occur in a whole crypt. These
percentages are likely to be different in different tissues and
situations.
Composition of the denominator
Very similar uncertainties exist in relation to the compart-
mentalisation of the denominator of the apoptotic index or
labelling index. This complication is significantly reduced in
situations analogous to our studies in the intestinal
epithelium, where the cell types at each cell position in the
crypt, or in the crypt as a whole, are fairly well understood
and defined. However, this is not the case in many other
tissues and is certainly not the case in random sections cut
through tumours. Here, there is the added major complica-
tion that tumours often contain large or even microscopic
foci of necrosis and, at the level of the light microscope, it
could be very difficult to distinguish necrotic and apoptotic
cells. There are also major differences in the growth rates of
cells at different locations within any given tumour, and there
may well be similar differences in the rate of cell death.
Flow cytometric approaches
Another consideration is the fact that techniques are
increasingly being adopted for measuring the apoptotic
index using flow cytometry. Here, as with all flow
cytometric analysis, the precise characteristics of the cells
that constitute the denominator are uncertain and are
probably variable. This partially explains the frequent
discrepancy between S-phase fractions flow cytometrically
determined and tritriated thymidine or labelling indices
determined using bromodeoxyuridine from histology pre-
parations. Such discrepancies between flow cytometry and
histomeric measurements are also to be expected when
apoptosis is the end point, but will be exacerbated by the
fact that a wide variety of different technical approaches
have been adopted for identifying apoptotic cells using the
flow cytometer (hypodiploid fractions, specific stains, end
labelling techniques, etc). Thus, comparisons between
apoptotic indices determined flow cytometrically from one
tissue and one laboratory and those determined in another
laboratory should be viewed with caution. Even greater
caution should be observed when comparing flow cytometric
measurements with measurements based on morphological
criteria in tissue sections.
In vitro vs in vivo systems
A particular uncertainty may exist here relating to in vitro
systems as flow cytometric approaches can often be applied
to such systems. A question that has not been, to my
knowledge, adequately addressed is whether the apoptotic
response of cells in culture bears any relationship to the
behaviour of the same cell types in vivo. Cell culture systems
are clearly of great value in characterising the process of cell
death and identifying the genes, cellular checkpoints and
mechanisms involved. Certainly, cell cycle times in vitro often
bear little relationship to those of the same cell types in vivo.
However, these questions and those relating to how
intercellular communication and interactions with the
extracellular matrix influence apoptosis and apoptosis-
related gene expression in vivo are currently being addressed
in part by the use of appropriate in vitro systems. Some
attempts to address these questions have been made using
transfected rat fibroblasts grown in vitro and subcutaneously
in immune-deficient mice. (Arends et al., 1994). Here, it has
been shown that cells with a high apoptotic rate in vitro
produced slow-growing tumours with a high level of
apoptosis, and the converse was also true. These authors
also used the ratio of apoptosis to mitosis to reduce the
complications attributable to the poorly defined composition
of the denominator, an approach also suggested by Allan et
al. (1992).
One point to bear in mind here is that, in most cases, in
order to grow cells in culture, survival signals and conditions
have inevitably been maximised. This may be to the
detriment of our ability to induce apoptosis. Thus, although
a given agent or treatment may be capable of overcoming the
in vivo counter apoptosis or survival signals and triggering
apoptosis, the same treatment in vitro may not be capable of
overcoming the stronger survival signals and survival
environment. Thus, it may be necessary to remove growth/
survival factors in vitro before apoptosis can be triggered.
These concepts inevitably raise the question of whether
survival or death signals are the basic instructions for cells.
Arguments can be presented to suggest that death (apoptosis)
is the fall-back (default) status for all cells (Raff, 1992). The
fact that they do not usually express this state is because of
the presence of survival factors or genes.PO Apoptotic index
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Variety of identification techniques, e.g. in situ end labelling vs
morphology
One further point relating to the determination of apoptotic
indices, whether using flow cytometry or histological sections,
concerns the use oftechniques designed to detect breaks in the
DNA strands. Degradation of the DNA via specific endonu-
cleaseenzymesisanintegralpartoftheapoptoticprocess. Thein
situ broken-strand detection techniques have been readily
accepted by many in the field but have rarely been accurately
validatedagainst agenerally accepted standard. Thequestion of
what this standard should be remains open. However, in my
view, the easily recognisable morphological changes that are
seen in haematoxylin and eosin-stained sections oftissues such
as the gut, and which have been described in relation to
apoptosis, should at present be the reference standard. Few
using in situ end labelling (ISEL) techniques provide informa-
tion about the number offalse positives and false negatives that
they have obtained. In our experience with the small intestine,
these techniques are notoriously capricious, difficult to use and,
underoptimal conditions, there arestill afewfalsepositives (i.e.
0.3-1.6% ISEL-stained cells that show no morphology
associated with apoptosis) and many cells that represent false
negatives (i.e. 17.3-35% cells that are not ISEL stained but
show the morphological criteria of apoptosis) (Merritt et al.,
1996). The variability of these numbers depends on the
techniques and samples studied. In my view, it would at
present be dangerous to attempt to relate apoptotic indices,
determined using such end labelling techniques, with data
obtained when morphological criteria are considered. There is
the additionalquestion ofwhethersuchendlabellingtechniques
can distinguish between breaks induced by a particular
treatment regimen (i.e radiation exposure) and those involved
in the necrotic degradation ofcells (Ansari etal., 1993). There is
also someindication thatthe DNA becomes progressively more
degraded with delay in fixation (Hall et al., 1994). Thus, in
tumour samples subjected to end labelling approaches and
analysed in the flow cytometer, it might be expected that no
distinction could be made between cells from a necrotic centre
and apoptoticcells inhealthy growing tumour tissue. It isworth
noting that in some tissues, for example the testis during
spermatogenesis, both necrosis and apoptosis occur as part of
the natural events and both are enhanced following exposure to
agents such as radiation (Allan et al., 1987). The testis is also a
classicexample ofthe strong hierarchicaldependence ofboth of
these processes in terms ofthe celllineages thatcharacterise this
tissue (see below). ISEL is but one example of the expanding
rangeofdetectionapproaches beingused. Theseincludevarious
modifications of end labelling procedures which involve
different labelled precursors and different enzymes, e.g.
deoxynucleotidyl transferase rather than DNA polymerase.
Their use without validation using a reference standard makes
comparisons difficult.
It is interesting that, using carefully controlled techniques
on rapidly fixed tissue, the ISEL approach on sections has
been used to demonstrate the occasional apoptotic cell on or
near the tips of the villus (Hall et al., 1994). It can be
estimated that the number of apoptotic cells on the villus as a
whole is close to that expected if all senescent cells initiated
apoptosis at the end of their life. This senescent cell suicide
may have different temporal and even genetic regulation to
that of spontaneous and damage-induced apoptosis in the
crypt. The expression of the cell death gene Bax is
particularly evident on the villus tip but absent even from
irradiated crypts (J Wilson and CS Potten, unpublished data).
Spontaneous or naturally occurring apoptosis in the crypts is
p53-independent while radiation-induced apoptosis is p53-
dependent (Merritt et al., 1994).
Hierarchical dependence
Another point that I wish to raise is the possibility that
apoptosis in a given tissue or tumour may be strongly
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Figure 3 Schematic half-crypt section and the cellular hierarchy
(left) that describes cell replacement in the crypt. The stem cells
are believed to be located at about the fourth cell position from
the base. The first three positions contain Paneth cells. Apoptotic
fragments are shown at position 5, a mitosis at position 10 and a
goblet cell at position 12. A range of cytotoxic agents target cells
at positions 4-6, others target cells at positions 6-8 and yet
others at positions 9-11. These studies involved a wide range of
doses and a range of sampling times for each of the 18 cytotoxic
agents studied initially (see Ijiri and Potten, 1987a, b; Li et al.,
1992). S, stem cells; T, transit cells.
dependent on the hierarchical status of the cells within the
tissue. As already mentioned, this is clearly evident during the
process ofspermatogenesis, but it is also very clear that in the
small intestine spontaneous, radiation-induced and some
drug-induced apoptosis is associated with the stem cell
compartment (Potten, 1977, 1992; Ijiri and Potten, 1987a;
Li et al., 1992; Potten et al., 1992) (Figure 3). Transit cells are
capable of undergoing apoptosis following exposure to other
cytotoxic agents and so possess the programme for this mode
of death. However, following exposure to radiation or certain
cytotoxics and chemical mutagens they cannot be forced to
activate this programme (Ijiri and Potten, 1987b; Potten,
1992). Virtually nothing is known about the hierarchical
dependence of apoptosis whether it be spontaneous (i.e.
related to proliferation) or damage induced in most tissues of
the body or in tumours.
In the small intestine, however, we believe that the ability
to induce apoptosis by a particular agent is related to the
cellular heirarchy or lineage present; in other situations it
may be related to age, differentiation status, etc. The
senescent cell death outlined in the previous section is
perhaps an interesting example here. In the intestine, some
spontaneous apoptosis, which we believe is part of the stem
cell homeostatic process, and some damage-induced apopto-
sis seems to have some specificity for the cells earliest in the
lineage, but apoptosis also seems to be initiated in senescent20
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Figure 4 An actual cell position plot for the apoptotic bodies
observed 4.5h following a dose of 1 Gy of 137CS y-rays (200 crypt
sections from four mice) compared with the hypothelial
distribution of actual stem cells and clonogenic (potential) stem
cells (see Potten and Loeffler, 1990). The theoretical distributions
were based on mathematical models of the crypt, which included
data on the Paneth cell distribution, for which I am grateful to
Drs Loeffler and Paulus. The distribution of proliferative cells is
considerably broader with peak values at about cell position 10
rather than cell positions 4 and 5.
cells at the end of their life span at the opposite pole of the
tissue. It should be noted that those agents that induce
apoptosis in cells early in the lineage tend to have an
apoptotic cell positional frequency plot similar to the
distribution plot hypothesised for the stem cells based on
mathematical modelling studies (unpublished data). The stem
cells have a considerable spread in position owing to the
spread in the Paneth cell distribution and uncertainties in
section orientation (see Figure 4). The apoptotic distribution
is compounded by these complications plus those already
outlined and the fact that the cells carrying the apoptotic
bodies move with the passage of time.
This problem of relating the measured index to cells of
differing hierarchical status was, I believe, one major problem
faced when relating cell kinetics to clinical applications. The
cell cycle characteristics of the crucial stem cells were what
was desired, but almost invariably what was measured was
the cell cycle characteristics of the predominant dividing
transit populations. The same is likely to be true for
apoptotic indices.
Stability in surgical or biopsy specimens
A final consideration not often taken into account by those
working with proliferative indices (mitotic index and labelling
index) and apoptotic indices is the robustness of the cell cycle
progression activity and the processes of mitosis and DNA
synthesis once the vascular supply has been disrupted during
surgery. Many clinical specimens are obtained at a somewhat
variable time after surgery but, even if the specimens are
obtained as rapidly as possible after excision and are
appropriately fixed, it is common surgical practice to clamp
off the vascular supply early during a surgical procedure and
Apoptotic index
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excise the tissue at a later time. Thus, cells are deprived of
oxygen and nutrients for a variable length of time. Good
fixation is crucial for apoptosis in tissue sections. In our
experience, DNA synthesis tends to be fairly robust, whereas
mitosis and cell cycle progression may be much more
sensitive. Cells in mitosis may start to die once the vascular
supply has been disrupted and show characteristics of
apoptosis. Entry into mitosis and into S-phase may be
blocked, and if oxygen and nutrients are restricted for more
than a brief critical time cells may die from any point in the
cell cycle. Thus, although certain proliferative parameters
(notably mitotic index) may decrease with the passage oftime
from the occlusion of blood vessels, the proportion of
apoptotic or dying cells may actually increase. Again, these
processes have not been extensively studied.
Conclusions
I certainly do not wish to be negative and suggest that
apoptotic indices should not be measured, but I do suggest
that considerable caution be exerted in the interpretation of
the data obtained, particularly when comparing one sample
with another and data from one laboratory with another.
Some of the points that I have outlined should be taken into
consideration. Some are relatively easy to accommodate, e.g.
defining scoring criteria and detection thresholds, controlling
fixation, avoiding comparisons between disparate systems,
etc. Others may be more difficult, e.g. determining the
duration of apoptosis, ascertaining whether a hierarchical
dependence exists, etc.
There are other considerations that probably fall outside
the scope of this commentary. These include the semantic-
philosophical arguments concerning the definition of cell
death - at what point does cell death occur and how do we
recognise it? There are also the related ambiguities on the
definition of programming: the distinction between cell
suicide and cell murder and the often interchangeable use
of the broader term programmed cell death and the specific
term apoptosis, which can lead to confusion rather than
clarity. These points inevitably also include the consideration
of metabolic, morphological and functional or physiological
death. In this article, I have concentrated on the
morphological aspects. A particular physiological aspect is
the loss of the reproductive potential of a cell. This definition
of cell death is one commonly used by radiobiologists when
clonal regeneration assays are used. There is a relatively clear
distinction between, on the one hand, a previously
reproductively active cell becoming completely sterile
(incapable of any more cell divisions) and, on the other
hand, a cell which can satisfy the clonogenic criterion of
forming a clone containing a certain number of cells.
However, in between are many categories of 'doomed' cells,
cells with slowed growth, cells with limited division capacity
and cells that prematurely differentiate. Furthermore, it is
unclear whether a completely sterilised cell necessarily
undergoes any morphological changes that would enable
one to recognise it as apoptotic or necrotic. It is for these
sorts of reasons that the apoptotic yield rarely relates to the
yield of reproductively sterilised cells, at least in the gut
(Potten, 1977; Hendry and Potten, 1982).
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